Logo
  • Newsroom
  • Careers
  • Contact Us
  • Home
  • About Us
  • Products
  • Manufacturing
  • R & D
  • Responsibility
  • Investors
  • Vision & Mission Leadership Structure Corporate GovernanceBusiness Conduct & EthicsBusiness OpportunitiesGlobal OperationsHistory
  • Formulations Active Pharamaceutical Ingredients
  • GoaBaddiGhaziabadSikkimRohaPithampur
  • Research Centre - Goa Priority Areas Biotechnology CapabilitiesResearch Alliances & Partnerships
  • Values & Commitments Environment, Health & Safety Quality & Reliability CSR
  • Financial highlightsCEO & CFO Certifications Shareholder Information Contacts
News Room

Home Newsroom

News Room

 

October 07, 2011
Press Release - Unichem Laboratories receives ANDA approval from USFDA for LAMOTRIGINE TABLETS..........
April 07, 2011
Press Release - Unichem Laboratories receives ANDA approval from USFDA for .........
December 14, 2010
Press Release - Unichem Laboratories to secure their brands against...
October 19, 2010
Press Release - Clarification on NPPA Price Fixation Order Dated October 11, 2010
September 23, 2010
Press Release - Unichem Laboratories receives CEP for Alfuzosin Hydrochloride..........
August 03, 2010
Press Release - Unichem receives ANDA approval from USFDA for...
March 03, 2010
Press Release - Unichem granted EU GMP certificate...
February 19, 2010
Press Release - Unichem receives CEP for Meloxicam...
February 19, 2010
Press Release - Unichem receives CEP for Zolpidem Tartrate...
February 04, 2010
Press Release - Ghaziabad facility recertified by MHRA, U.K…
January 20, 2010
Press Release - Unichem receives ANDA approval from USFDA for…
December 04, 2009
Press Release - Niche Generics Ltd receives Marketing Authorizations for “Anastrozole”
November 10, 2009
Press Release - Unichem received approval from US FDA for Pithampur API facility…
August 27, 2009
Press Release - Unichem receives ANDA approval from USFDA for…
August 19, 2009
Press Release - Unichem receives ANDA approval from USFDA for…

Did you know?

  • Many of Unichem’s manufacturing facilities are FDA approved
  • Over 65% of depressed people don’t seek treatment
  • Our product, Losar is the #1 anti-hypertensive brand in India
  • More than 2% of pharmaceutical patenting in the US is by India-based inventors
Losar 25
© 2009 UNICHEM
  • Terms of Use
  • Sitemap
Designed by: Indigo Consulting